Fact CheckerSign in

NCT05862584Completed

Impact of Air Pollution on the Course of Inflammatory Rheumatism

Impact of Air Pollution on the Course of Inflammatory Rheumatism: a Prospective, Single-center Study

Source: ClinicalTrials.gov · Last updated 22 May 2026

Brief summary (registry, in English)

The objective of this study is to see if there is a link between air pollution and inflammatory rheumatism (rheumatoid arthritis and ankylosing spondylitis) To do this, the investigators are going to follow a cohort of about 200-400 patients for 6 months by means of a self-questionnaire, which the investigators ask the patient to fill in once a week on a fixed day, and opposite the corresponding week to put the letter corresponding to the question concerning the activity of your disease: 3 possible answers: A: no flare-up, B: short flare-up of 1 to 3 days, C: persistent flare-up of more than 3 days Then the investigators will collect the questionnaire at the end of these 6 months and at each visit to the consultation or day hospital (on average every 4 to 6 weeks), and they will look to see if any relapses have occurred. At the same time the investigators will calculate the disease activity score (DAS or BASDAI) to have an objective score. Then in parallel they will look at the level of exposure to air pollution according to the place of residence and work of each patient. The hypothesis is that air pollution has an influence on the activity of inflammatory rheumatism.

Status (registry)
Completed
Study type
Interventional
Enrollment
86 (actual)
First submitted
24 Apr 2023
Start date
26 May 2023
Primary completion date
23 Jan 2024
Lead sponsor
Centre Hospitalier Universitaire de Nice
NCT number
NCT05862584

What you commit to

  • Study type: Interventional
  • Participants enrolled: 86
  • From 26 May 2023 to the primary completion date, 23 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patient with no fixed abode
  • Patient planning to move within 6 months.
  • Patient unable to read or understand the non-opposition notice.

Who the study is looking for

  • Patients with RA according to ACR/EULAR 2010 criteria, or spondyloarthritis according to ASAS criteria.
  • Patients older than 18 years of age
  • Patients with RA or spondyloarthritis considered stable (no change in background or biological therapy for at least 3 months) and in low activity (SAR 28 CRP \< 3.2 for RA and BASDAI \< 4 for 3 months).
  • Patient treated with biological therapy

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nice University Hospital
Coordinator of this site? Confirm its status
NiceFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.